Jessica Men

Articles

Canagliflozin Trial Finds Increased Risk of Amputations

June 02, 2016

Interim results from the ongoing CANVAS (Canagliflozin Cardiovascular Assessment Study) clinical trial have found an increased risk of leg and foot amputations associated with the popular diabetes medication.